Response of hypercholesterolemic subjects to administration of tocotrienols

• Published in: Lipids Vol. 30; no. 12; pp. 1171 - 1177
• Main Authors: Qureshi, A.A. (Advanced Medical Research, Madison, WI.), Bradlow, B.A, Brace, L, Manganello, J, Peterson, D.M, Pearce, B.C, Wright, J.J.K, Gapor, A, Elson, C.E
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer‐Verlag 01.12.1995
• Subjects: ACTIVIDAD ENZIMATICA; ACTIVITE ENZYMATIQUE; administration & dosage; Adult; analogs & derivatives; Apolipoproteins B; Apolipoproteins B - blood; blood; Blood Glucose; Blood Glucose - metabolism; CHOLESTEROL; Cholesterol - blood; Cholesterol, LDL; Cholesterol, LDL - blood; Chromans; Chromans - administration & dosage; Chromans - therapeutic use; COLESTEROL; DIET; DIETA; drug therapy; DRUGS; Energy Intake; enzyme activity; ENZYMIC ACTIVITY; FEMME; HIPERLIPIDEMIA; HOMBRES; HOMME; HUMAN NUTRITION; Humans; HYPERCHOLESTEROLEMIA; Hypercholesterolemia - blood; Hypercholesterolemia - drug therapy; HYPERLIPIDAEMIA; HYPERLIPIDEMIE; ILLINOIS; MEDICAMENT; MEDICAMENTOS; MEN; metabolism; Middle Aged; MUJERES; NUTRICION HUMANA; NUTRITION HUMAINE; nutritional intervention; Palm Oil; Plant Oils; Plant Oils - administration & dosage; Plant Oils - therapeutic use; REGIME ALIMENTAIRE; therapeutic use; TOCOTRIENOL; TOCOTRIENOLES; TOCOTRIENOLS; Vitamin E; Vitamin E - administration & dosage; Vitamin E - analogs & derivatives; Vitamin E - therapeutic use; WOMEN; Illinois

The cholesterol‐suppressive actions of Palmvitee and γ‐tocotrienol were assessed in hypercholesterolemic subjects after acclimation to the American Heart Association Step 1 dietary regimen for four and eight weeks, respectively. The four‐week dietary regimen alone elicited a 5% decrease (P<0.05)...